Loading
Latest filing published 20 Mar 2023 for Galera Therapeutics, Inc., €23k. Read the official filing
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Only one filing by Mark Bachleda is known so far (20 March 2023): an open-market purchase, €23k, in Galera Therapeutics, Inc. That is too little to draw conclusions. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration